| Name | Title | Contact Details |
|---|
American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. With more than three decades of expertise in all areas of oncology practice management, AON enables physicians to focus on what matters most – providing the highest quality care for patients. We preserve and protect the sustainability of community oncology for physicians, patients and partners, so practices thrive. Ensure that every American has local access to exceptional cancer care. AON provides comprehensive administrative support and ancillary services that help community oncology practices thrive in an increasingly complex healthcare environment. Our collaborative approach and physician-led model allows practices to maintain local leadership and autonomy. With over three decades of successfully improving and advancing community oncology practices, we have developed a proven business model that allows practices to benefit from our scale and expertise in such critical areas as drug-procurement and payer contracting, as well as practice diversification through central lab and pathology, specialty pharmacy. AON was created and is led by the leadership team responsible for the success of Florida Cancer Specialists & Research Institute, the nation`s largest independent community oncology practice. Our team has vast experience in complex and diverse group practice integration and is able to ensure a smooth and successful transition process for local practices that choose to become a part of the AON.
Excerpted from the website description: Jefferson Radiology Group is a partnership of more than 30 radiologists, offering Sub-Specialized diagnostic and interventional imaging services. All the physicians in the Group, who are Board Certified, are committed to delivering the highest quality of radiology and imaging services as possible.
Prescient Surgical, Inc. is a medical device innovator that makes advanced tools and technologies to fight and defend against the sources of surgical site infection.
NanoHybrids specializes in research and commercialization of nanotechnology-based products that enhance diagnosis and therapy for cancer and other diseases through enhanced molecular imaging and profiling. Our molecular imaging nanoparticles enhance contrast in vitro and in vivo across multiple biomedical imaging modalities. We are the leading provider of silica-coated gold nanoparticles optimized for photoacoustic (optoacoustic) imaging. With conjugation services we provide nanoparticles with high specificity for targeted cell receptors and tailored to individual applications. Our nanoparticles improve signal strength and allow real time imaging of functional biology. Interested in learning how we are using nanotechnology to drive advances in the life-sciences? Want learn more about our research, products, or services? Contact us, and let`s talk.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,400 people across 40 countries.